. The AGM station. The onset of HSC activity in the placenta region develops from the para-aortic splanchnopleura parallels that of the AGM (aorta-gonad-mesonephros) and represents another independent site for de novo region starting at E10.5-E11.0. However, the placental hematopoiesis. As HSCs in the AGM region are only HSC pool expands until E12.5-E13.5 and contains found for a short time, and the number of HSCs and >15-fold more HSCs than the AGM. The expansion of progenitors is low at all times, the AGM is not considthe CD34 + c-kit + HSC pool in the placenta occurs prior ered to function as a major site for expansion or differto and during the initial expansion of HSCs in the fetal entiation of HSCs. Instead, accumulation of HSCs is liver. Importantly, the placental HSC pool is not exseen shortly thereafter in the fetal liver, which also plained by rare circulating HSCs, which appear later. serves as the main site for hematopoietic differentiation These data support an important, but unappreciated, during fetal life (Ema and Nakauchi, 2000) until hematorole for the placenta in establishing the mammalian poiesis shifts to the bone marrow around birth. As no definitive hematopoietic system. 
components of the fetal placenta upon fusion with the AGM region and the placenta. No LT-RUs were yet found in the fetal liver rudiment or in circulating blood, chorion. The allantois develops from the epiblast during gastrulation and grows into the exocoelomic cavity as a although clonogenic progenitors were abundant (see below). By E11.5 (41-45 sp), the total number of LTmesodermal extension of the posterior primitive streak. The allantois fuses with the chorion at E8-E8.5 and RUs in the conceptus had increased to w11 ( Figure 1C ; Table 2 Table 2 ). These results show that the placenta represents yet another site at which adult coculture on rat thymic filler cells and plaque-forming cell assays (Melchers, 1979) . Since these early studies, reconstituting HSCs reside during mouse development. The onset of HSC activity in the placenta coincides with placental hematopoiesis has not been reassessed until Alvarez-Silva et al. showed by in vitro clonogenic asthat in the AGM and the yolk sac, and it precedes HSC seeding of the fetal liver. Importantly, placental HSCs says that the placenta is a rich source for multipotential hematopoietic progenitors before they colonize the feappear before HSCs can be detected in circulating blood. tal liver. The results of these assays suggest that the placenta may function as a hematopoietic organ during development (Alvarez-Silva et al., 2003). However, hemaPluripotency and Self-Renewal Ability topoietic progenitors in the mouse embryo form prior to of Placental HSCs and independently of HSCs that establish the definitive The multilineage potential of placental HSCs was verihematopoietic system. We therefore asked whether the fied by demonstrating the presence of fetus-derived placenta also supports the development of true HSCs CD45.1/CD45.2+ myeloid (Gr1/Mac1), B lymphoid (B220), that have the ability to self-renew and permanently reand T-lymphoid progeny (CD4/CD8) in the peripheral constitute all lineages of the adult hematopoietic system. blood of the recipient animals ( Figure 2A ). At E10.5, T-lymphoid lineage could not be confirmed for any fetal organs due to the low level of hematopoietic engraftResults ment, whereas, from E11.0 onward, placental HSCs, similar to the HSCs derived from the AGM region, were We performed a spatial and temporal analysis of HSC activity during mouse embryonic development by using able to give rise to multilineage long-term reconstitution for >5-10 months. Likewise, engraftment of plathe long-term transplantation assay, which is the most stringent and reliable assay for HSCs. In this study, we centa-derived hematopoietic cells had occurred in the bone marrow ( Figure 2B ), thymus, and spleen of the realso assessed HSC activity in the placenta, which has not been recognized as an organ that participates in cipient animals (data not shown). Furthermore, placental HSCs were able to self-renew in the recipient animals, as HSC development. Collagenase-treated hematopoietic organs from E10.5-E18.5 conceptuses were transdemonstrated by secondary transplantation of 1:10 and 1:100 fractions of BM from primary recipients that had planted in limiting dilutions, quantified as embryo equivalents (ee), into congenic, irradiated adult recipients tobeen transplanted with placenta (0.3-1 ee) and AGM-(1-3 ee) derived cells from E11.5 conceptuses (Figures gether with competitor bone marrow cells (Table 1) . Hematopoietic reconstitution by fetus-derived CD45.1/ 2B and 2C). These results show that HSCs located in the placenta possess functional properties of bona fide CD45.2 cells was analyzed by flow cytometry, and HSCs were quantified as repopulating units (RUs/ee). adult BM reconstituting hematopoietic stem cells.
Developmental Kinetics of Placental HSCs The Onset of HSC Activity in the Placenta
Rare hematopoietic cells (0.1 RUs/ee) capable of conand Progenitors To assess hematopoietic activity in the placenta betributing to peripheral blood of irradiated adult recipients over 10-12 weeks were found in the placenta alyond the time period when HSCs are generated in known hematopoietic sites, we defined the kinetics of ready at E10.5 (33-36 sp, somite pairs). The temporal emergence of these hematopoietic cells was similar to HSCs and progenitors throughout mid-and late gestation. Remarkably, between E11.5 and E12.5, a marked what was seen in the caudal half of the embryo and the yolk sac ( Figure 1A ; Table 2 ). However, RUs in the entire expansion of HSCs occurred in the placenta and the fetal liver (20-and 28-fold, respectively), whereas no conceptus were rare at this stage (0.3 RUs) and gave rise to very low (<1%-2%) hematopoietic reconstitution significant increase of the HSC pool was observed in the AGM region or the yolk sac ( Figure 3A ). Hematopoithat frequently was lost over time. At E11.0 (37-40 sp), the conceptus contained, on average, one long-term etic expansion in the placenta favored HSCs more than progenitors, as the clonogenic myeloerythroid progenirepopulating unit (0.48 LT-RUs in placenta, Figure 1B ; Table 2 ), and the first HSCs yielding a higher (>10%) tor pool in the placenta increased only 2-fold during this period ( Figure 3B) . The competitive repopulation level of hematopoietic reconstitution were seen in the ability of placental HSCs at this stage was high, resultnumbers those in the placenta by E15.5. Bone marrow seeding by clonogenic progenitors and rare cells that ing in sustained multilineage reconstitution that often increased over time, whereas fetal liver HSCs, although gave rise to transient in vivo reconstitution was evident at E15.5, whereas long-term reconstituting HSCs apalmost 2-fold higher in numbers at E12.5 (50 in the placenta and 93 in the fetal liver), were more heteropeared in the BM by the end of gestation ( Figure 3A ). In summary, the developmental kinetics of HSCs and geneous in reconstitution potential early on, as shown by lower competitive repopulation ability of fetal liver progenitors in the placenta is unique and does not reflect hematopoietic activity in any other fetal hematoHSCs at E12.5 (Table 2 ). At E13.5, the average competitive repopulation level of HSCs in the fetal liver was poietic organ or in circulating blood. similar to placental HSCs (data not shown).
The size of the placental HSC pool was maintained Surface Phenotype of Placental HSCs and Progenitors through E13.5, but it diminished >10-fold by E15.5, while the HSC pool in the fetal liver continued to exThe immunophenotype of placental HSCs and progenitors was defined by assaying subpopulations of cells pand ( Figure 3A) . From E12.5 onward, a gradual increase of LT-RUs in fetal circulation occurred, exceeding in that had been sorted based on CD34 and c-kit expres- . HSC activity in the umbilical cord was also assessed in this study in exceeds in numbers those in all other fetal hematopoietic organs other than the fetal liver. HSC activity, as some experiments, demonstrating the presence of HSCs in the cord, albeit at lower numbers than in the defined by adult BM reconstitution ability, in the mouse placenta (Table 2) . Whether de novo hemogenic activity also in the placenta, and may therefore represent another independent focus for de novo hematopoiesis, in extends into the placenta remains to be studied.
Previous Table 1 ). Figures 4B and 4C) days later by stem cells, when the vascular connections . Peripheral blood reand fetal hematopoietic tissues were dissected, and embryos were constitution over 10-12 weeks was regarded as positive HSC/RUs. exsanguinated for collection of fetal blood. At E9.5-E10.5, the caudal half of the embryo comprising the pSP (para-aortic splanchnopleura)/AGM region and the fetal liver rudiment was analyzed in
